John Skarlatos
About
In The Last Decade
John Skarlatos
19 papers receiving 803 citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 337
- Cancer Research 259
- Molecular Biology 238
- Oncology 237
- Biomedical Engineering 183
Countries citing papers authored by John Skarlatos
This map shows the geographic impact of John Skarlatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Skarlatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Skarlatos more than expected).
Fields of papers citing papers by John Skarlatos
This network shows the impact of papers produced by John Skarlatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Skarlatos. The network helps show where John Skarlatos may publish in the future.
Co-authorship network of co-authors of John Skarlatos
This figure shows the co-authorship network connecting the top 25 collaborators of John Skarlatos. A scholar is included among the top collaborators of John Skarlatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Skarlatos. John Skarlatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Hidradenocarcinoma of the temporal area successfully treated with concomitant electrochemotherapy and radiotherapy | 11 |
| 2 | Intraoperative radiation therapy on pancreatic cancer patients: a review of the literature. | 7 |
| 3 | 1 | |
| 4 | Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma. | 16 |
| 5 | 2 | |
| 6 | Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. | 246 |
| 7 | Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy. | 12 |
| 8 | 37 | |
| 9 | 51 | |
| 10 | 168 | |
| 11 | 2 | |
| 12 | 103 | |
| 13 | 47 | |
| 14 | 11 | |
| 15 | Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment. | 8 |
| 16 | 78 | |
| 17 | 11 | |
| 18 | 13 | |
| 19 | 1 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.